Organization · Venture Capital
Mitre Ventures
Mitre Ventures is a venture capital firm based in Chattanooga, Tennessee, focused on early-stage life science startups in the therapeutics sector. The firm aims to connect visionary founders with mission-aligned investors, primarily investing in pre-seed and seed-stage companies.
Overview
What Mitre Ventures does
What Mitre Ventures is
Mitre Ventures is a venture capital firm based in Chattanooga, Tennessee, focused on early-stage life science startups in the therapeutics sector. The firm aims to connect visionary founders with mission-aligned investors, primarily investing in pre-seed and seed-stage companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Mitre Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Mitre Ventures as a funder
Investment thesis
Mitre Ventures focuses exclusively on early-stage therapeutics startups in the U.S., investing from pre-seed to seed stages with a minimum expectation of demonstrated proof of concept.
Focus narrative
Mitre Ventures specializes in early-stage investments within the therapeutics sector, including oncology, central nervous system (CNS) disorders, and infectious diseases. The firm adopts an agnostic approach to disease indications and modalities, welcoming technologies that can generate therapeutics across various disease areas and mechanisms, such as CAR-T, CGT, mRNA, ASO, and small molecules.
Value beyond capital
Mitre Ventures provides strategic support to its portfolio companies by connecting them with mission-aligned investors and leveraging its expertise in the life sciences sector. The firm focuses on helping startups navigate the complexities of early-stage development and regulatory pathways in therapeutics.
Terms and economics
- Typical check
- $500,000–$1,500,000
Focus and fit
- Stages
- Pre-seed · Seed
- Sectors
- Cell Gene Therapy
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Currently, no specific portfolio companies have been disclosed as Fund I is actively fundraising and appears to be in its early stages.
Common questions
What to know about Mitre Ventures
Upseed classifies Mitre Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.